Delayed-onset malignant hyperthermia in association with rocuronium use.


PURPOSE Two cases of malignant hyperthermia suspected to be related to the use of a nondepolarizing neuromuscular blocker are reported. SUMMARY A pharmacogenetic disorder that may occur in as many as 1 in 3000 anesthesia procedures, malignant hyperthermia has been linked to the use of certain anesthetic gases and depolarizing neuromuscular blocking agents… (More)
DOI: 10.2146/ajhp110306


1 Figure or Table

Cite this paper

@article{Beggs2012DelayedonsetMH, title={Delayed-onset malignant hyperthermia in association with rocuronium use.}, author={Ashton E Beggs and Jennifer Quinn McCann and Jan M Powers}, journal={American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists}, year={2012}, volume={69 13}, pages={1128-34} }